Literature DB >> 3542107

On the mechanisms of kappa-opioid-induced diuresis.

T P Blackburn, K R Borkowski, J Friend, M J Rance.   

Abstract

In conscious saline loaded rats, the kappa-opioid agonists tifluadom, U50488, and ethylketocyclazocine, given subcutaneously, induced a characteristic diuresis which could be antagonized by naloxone. Bilateral adrenal demedullation significantly reduced adrenal gland catecholamine content and plasma adrenaline levels, but did not significantly affect plasma corticosterone levels, indicating that the adrenal cortex remained both intact and functional. Seven days following bilateral adrenal demedullation, the subcutaneous administration of the kappa-agonists no longer induced diuresis. However, demedullation did not affect the diuretic response to frusemide or clonidine, nor did it affect the antidiuretic response induced by the mu-opioid agonists morphine and buprenorphine. Adrenal catecholamines do not appear to be involved in kappa-opioid-induced diuresis, since pretreatment with propranolol, prazosin and idazoxan did not affect the diuretic response in intact animals. The results indicate a link between the adrenal medulla and kappa-opioid-induced diuresis and suggest that a peripheral mechanism may also be involved in mediating this effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542107      PMCID: PMC1917165          DOI: 10.1111/j.1476-5381.1986.tb11160.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  An approach to immunoassay.

Authors:  W H Walker
Journal:  Clin Chem       Date:  1977-02       Impact factor: 8.327

2.  A kappa opioid effect: increased urination in the rat.

Authors:  J D Leander
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

Review 3.  Multiple opioid receptors.

Authors:  E T Iwamoto; W R Martin
Journal:  Med Res Rev       Date:  1981       Impact factor: 12.944

4.  An opioid benzodiazepine.

Authors:  D Römer; H H Büscher; R C Hill; R Maurer; T J Petcher; H Zeugner; W Benson; E Finner; W Milkowski; P W Thies
Journal:  Nature       Date:  1982-08-19       Impact factor: 49.962

5.  Inhibition of ADH release in the rat by narcotic antagonists.

Authors:  M Miller
Journal:  Neuroendocrinology       Date:  1975       Impact factor: 4.914

6.  Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.

Authors:  E Castanas; P Giraud; Y Audigier; R Drissi; F Boudouresque; B Conte-Devolx; C Oliver
Journal:  Mol Pharmacol       Date:  1984-01       Impact factor: 4.436

7.  Unexpected opioid activity in a known class of drug.

Authors:  D Römer; H H Büscher; R C Hill; R Maurer; T J Petcher; H Zeugner; W Benson; E Finner; W Milkowski; P W Thies
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

8.  The effect of bilateral adrenal demedullation on vascular reactivity and blood pressure in spontaneously hypertensive rats.

Authors:  K R Borkowski; P Quinn
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

9.  Neurohypophysial hormones in the adrenal medulla.

Authors:  V T Ang; J S Jenkins
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

10.  Further study of kappa opioids on increased urination.

Authors:  J D Leander
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

View more
  8 in total

1.  Studies on the adrenomedullary dependence of kappa-opioid agonist-induced diuresis in conscious rats.

Authors:  K R Borkowski
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

2.  Kappa-opioid-receptor agonists modulate the renal excretion of water and electrolytes in anaesthetized rats.

Authors:  N Ashton; R J Balment; T P Blackburn
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Kappa-opioid-induced changes in renal water and electrolyte management and endocrine secretion.

Authors:  N Ashton; R J Balment; T P Blackburn
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

4.  The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist.

Authors:  G H Rimoy; D M Wright; N K Bhaskar; P C Rubin
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Influence of asimadoline, a new kappa-opioid receptor agonist, on tubular water absorption and vasopressin secretion in man.

Authors:  H J Kramer; W Uhl; B Ladstetter; A Bäcker
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

6.  Generation of a KOR-Cre knockin mouse strain to study cells involved in kappa opioid signaling.

Authors:  Xiaoyun Cai; Huizhen Huang; Marissa S Kuzirian; Lindsey M Snyder; Megumi Matsushita; Michael C Lee; Carolyn Ferguson; Gregg E Homanics; Alison L Barth; Sarah E Ross
Journal:  Genesis       Date:  2015-12-18       Impact factor: 2.487

7.  The effects of idazoxan and other alpha 2-adrenoceptor antagonists on urine output in the rat.

Authors:  H C Jackson; I J Griffin; S D Birkett; D J Nutt
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

8.  Mechanism of diuretic action of spiradoline (U-62066E)--a kappa opioid receptor agonist in the human.

Authors:  G H Rimoy; N K Bhaskar; D M Wright; P C Rubin
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.